Your Evidence-Based Medication Guide

MedSwitcher covers GLP-1 weight loss medications (Ozempic, Wegovy, Zepbound, Mounjaro, Foundayo), peptide therapy (BPC-157, Thymosin Alpha-1, CJC-1295, and more), antidepressant switching (SSRIs, SNRIs, cross-tapers), TRT, HRT, and other specialty medications. We add new categories regularly.

In many cases, yes — but timing matters. Our calculator maps your current dose to the closest equivalent on the target medication and suggests the optimal titration entry point. Always confirm the plan with your prescriber.

Costs vary dramatically — from $0 with manufacturer savings cards to over $1,500/month without insurance. Our cost comparison tool factors in your insurance status, available coupons, and pharmacy options to give you the real number.

Yes. Our peptide guides cite peer-reviewed research and clearly distinguish between FDA-approved uses, off-label applications, and investigational compounds. We track FDA reclassification status in real-time and note when evidence is limited.

Common reasons include inadequate response after adequate trial duration, intolerable side effects, cost barriers, or lifestyle considerations (e.g., preferring a pill over injection). Our guides outline the specific signals for each medication class. Always discuss changes with your healthcare provider.

Absolutely not. MedSwitcher is an educational tool that helps you prepare for conversations with your healthcare provider. We provide clinical data, dose mapping, and evidence-based guides — your doctor provides medical judgment for your specific situation.